Vibegron Disease Interactions
There is 1 disease interaction with vibegron.
Moderate
Vibegron (applies to vibegron) urinary retention
Moderate Potential Hazard, Moderate plausibility.
Vibegron may increase the risk of urinary retention, particularly in patients with bladder outlet obstruction and in those taking muscarinic antagonist medications to treat overactive bladder (OAB). It is recommended to monitor for signs and symptoms of urinary retention and discontinue the use of vibegron if a patient develops urinary retention.
References
- (2021) "Product Information. Gemtesa (vibegron)." Urovant Sciences, Inc
Vibegron drug interactions
There are 17 drug interactions with vibegron.
More about vibegron
- vibegron consumer information
- Check interactions
- Compare alternatives
- Reviews (158)
- Side effects
- Dosage information
- During pregnancy
- Drug class: urinary antispasmodics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.